{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:56:07Z","timestamp":1782568567185,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30 CA68485-19"],"award-info":[{"award-number":["5P30 CA68485-19"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jneuroim.2023.578219","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T03:33:00Z","timestamp":1696390380000},"page":"578219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Inhibition of SUMOylation promotes remyelination and reduces IL-17 mediated autoimmune inflammation: Novel approach toward treatment of inflammatory CNS demyelinating disease"],"prefix":"10.1016","volume":"384","author":[{"given":"Kwang Woon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Ljunggren-Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranathi","family":"Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Toki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2023.578219_bb0005","doi-asserted-by":"crossref","first-page":"43846","DOI":"10.1038\/srep43846","article-title":"Screening with an NMNAT2-MSD platform identifies small molecules that modulate NMNAT2 levels in cortical neurons","volume":"7","author":"Ali","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0010","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm.2110","article-title":"T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis","volume":"16","author":"Axtell","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.expneurol.2016.06.033","article-title":"A mouse model for testing remyelinating therapies","volume":"283","author":"Bai","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0020","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1038\/s41598-018-31477-4","article-title":"Elucidating the transactivation domain of the pleiotropic transcription factor Myrf","volume":"8","author":"Choi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007754","article-title":"What is the optimal value of the g-ratio for myelinated fibers in the rat CNS? A theoretical approach","volume":"4","author":"Chomiak","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2023.578219_bb0030","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.neuroscience.2009.09.069","article-title":"Functional recovery of callosal axons following demyelination: a critical window","volume":"164","author":"Crawford","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2023.578219_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.devcel.2012.11.020","article-title":"SUMO: a multifaceted modifier of chromatin structure and function","volume":"24","author":"Cubenas-Potts","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jneuroim.2023.578219_bb0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ni.3342","article-title":"Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing","volume":"17","author":"Decque","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2023.578219_bb0050","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.celrep.2016.06.056","article-title":"Protein SUMOylation is required for regulatory T cell expansion and function","volume":"16","author":"Ding","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0055","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.celrep.2015.10.001","article-title":"Global reprogramming of host SUMOylation during influenza virus infection","volume":"13","author":"Domingues","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00401-017-1741-7","article-title":"Myelin regulatory factor drives remyelination in multiple sclerosis","volume":"134","author":"Duncan","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0065","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.celrep.2018.04.089","article-title":"Phosphorylation state of ZFP24 controls oligodendrocyte differentiation","volume":"23","author":"Elbaz","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cell.2009.04.031","article-title":"Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination","volume":"138","author":"Emery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2023.578219_bb0075","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrmicro3015","article-title":"Interplay between viruses and host sumoylation pathways","volume":"11","author":"Everett","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev-biochem-061909-093311","article-title":"Sumoylation: a regulatory protein modification in health and disease","volume":"82","author":"Flotho","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0085","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrm3011","article-title":"The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition","volume":"11","author":"Gareau","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0090","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.febslet.2006.02.011","article-title":"Sumoylation of the SOX10 transcription factor regulates its transcriptional activity","volume":"580","author":"Girard","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0095","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/MCB.25.7.2688-2697.2005","article-title":"Ikaros SUMOylation: switching out of repression","volume":"25","author":"Gomez-del Arco","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2016.04.003","article-title":"The implication of SUMO in intrinsic and innate immunity","volume":"29","author":"Hannoun","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0105","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nchembio.2463","article-title":"Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor","volume":"13","author":"He","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0110","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1038\/s41467-018-07203-z","article-title":"Sumoylation of RORgammat regulates TH17 differentiation and thymocyte development","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.biochem.73.011303.074118","article-title":"Protein modification by SUMO","volume":"73","author":"Johnson","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0120","doi-asserted-by":"crossref","first-page":"46686","DOI":"10.1038\/srep46686","article-title":"Histological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination model","volume":"7","author":"Khodanovich","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0125","doi-asserted-by":"crossref","first-page":"12528","DOI":"10.1523\/JNEUROSCI.1069-12.2012","article-title":"Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS","volume":"32","author":"Koenning","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0130","doi-asserted-by":"crossref","first-page":"23033","DOI":"10.1074\/jbc.273.36.23033","article-title":"Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients","volume":"273","author":"Kuhlbrodt","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0135","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.it.2021.09.005","article-title":"RORgammat protein modifications and IL-17-mediated inflammation","volume":"42","author":"Kumar","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0140","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/acs.jmedchem.0c01491","article-title":"Discovery of TAK-981, a first-in-class inhibitor of SUMO-activating enzyme for the treatment of Cancer","volume":"64","author":"Langston","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.conb.2009.08.004","article-title":"Two-tier transcriptional control of oligodendrocyte differentiation","volume":"19","author":"Li","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0150","article-title":"Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling","volume":"8","author":"Liu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2023.578219_bb0155","doi-asserted-by":"crossref","first-page":"21527","DOI":"10.1073\/pnas.2006566117","article-title":"Anacardic acid induces IL-33 and promotes remyelination in CNS","volume":"117","author":"Ljunggren-Rose","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.22593","article-title":"Olesoxime accelerates myelination and promotes repair in models of demyelination","volume":"71","author":"Magalon","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0170","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P","article-title":"Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury","volume":"58","author":"McGavern","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0175","doi-asserted-by":"crossref","first-page":"102647","DOI":"10.1016\/j.autrev.2020.102647","article-title":"The role of TH17 cells in multiple sclerosis: therapeutic implications","volume":"19","author":"Moser","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0180","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1101\/gr.154872.113","article-title":"Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation","volume":"23","author":"Neyret-Kahn","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0185","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","article-title":"Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions","volume":"43","author":"Patel","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2023.578219_bb0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10571-012-9895-2","article-title":"Effect of leukemia inhibitory factor on the myelinogenic ability of Schwann-like cells induced from human adipose-derived stem cells","volume":"33","author":"Razavi","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0195","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41598-020-58709-w","article-title":"Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis","volume":"10","author":"Robinson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.07.004","article-title":"Post-translational regulation of RORgammat-A therapeutic target for the modulation of interleukin-17-mediated responses in autoimmune diseases","volume":"30","author":"Rutz","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0205","first-page":"53764","article-title":"Preparation of rat oligodendrocyte progenitor cultures and quantification of oligodendrogenesis using dual-infrared fluorescence scanning","author":"Schott","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0210","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1038\/s41467-018-06924-5","article-title":"SUMOylation of ROR-gammat inhibits IL-17 expression and inflammation via HDAC2","volume":"9","author":"Singh","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0215","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/glia.23636","article-title":"Transcriptional control of myelination and remyelination","volume":"67","author":"Sock","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2023.578219_bb0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1101\/gad.215802","article-title":"Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10","volume":"16","author":"Stolt","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0225","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.neuroimage.2010.10.065","article-title":"Fast bound pool fraction imaging of the in vivo rat brain: association with myelin content and validation in the C6 glioma model","volume":"54","author":"Underhill","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.jneuroim.2023.578219_bb0230","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ni.3742","article-title":"Interleukin 17 is a chief orchestrator of immunity","volume":"18","author":"Veldhoen","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0235","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.4049\/jimmunol.1600980","article-title":"Ubc9 is required for positive selection and late-stage maturation of thymocytes","volume":"198","author":"Wang","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0240","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135935","article-title":"Increased SUMO-activating enzyme SAE1\/UBA2 promotes glycolysis and pathogenic behavior of rheumatoid fibroblast-like synoviocytes","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jneuroim.2023.578219_bb0245","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.ijbiomac.2021.10.209","article-title":"Predicting signaling pathways regulating demyelination in a rat model of lithium-pilocarpine-induced acute epilepsy: A proteomics study","volume":"193","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jneuroim.2023.578219_bb0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.brainresrev.2010.04.002","article-title":"Targets and consequences of protein SUMOylation in neurons","volume":"64","author":"Wilkinson","year":"2010","journal-title":"Brain Res. Rev."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823002059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823002059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:43:45Z","timestamp":1759049025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823002059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":50,"alternative-id":["S0165572823002059"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578219","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of SUMOylation promotes remyelination and reduces IL-17 mediated autoimmune inflammation: Novel approach toward treatment of inflammatory CNS demyelinating disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578219"}}